Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1465687

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sepsis: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS hospitals follow the sepsis six care pathway approach; and if he will make a statement.
tabling member constituency	North East Hertfordshire
tabling member printed	Sir Oliver Heald
uin	8938
answer	answer is ministerial correction date of answer 13/06/2022 answer text <p>The information requested is not held centrally. However, all 29 pathology networks in the National Health Service in England have the capability to undertake the tests required to support the diagnosis of sepsis. Healthcare providers are encouraged to adopt the National Early Warning Score (NEWS2) which supports clinicians to identify and respond to patients at risk of acute deterioration, including those with suspected sepsis.  Since 2019, NEWS2 has been implemented in 100% of ambulance trusts and all except one acute trust in England.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 13/06/2022 14:52:13 answering member 4492 label Biography information for Maria Caulfield
tabling member	69 label Biography information for Sir Oliver Heald

1465691

registered interest
date	25/05/2022
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Hydrogen Fuelling Stations
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether he has had discussions with the Secretary of State for Transport on ensuring that the provision of hydrogen refuelling infrastructure for transport is considered in the development of new hydrogen production facilities.
tabling member constituency	Kilmarnock and Loudoun
tabling member printed	Alan Brown
uin	9040
answer	answer is ministerial correction date of answer 14/06/2022 answer text <p>The Department continues to work closely with the Department for Transport on the role of hydrogen in decarbonising transport. Government support has included £30m for refuelling infrastructure, which helps support the deployment of 124 hydrogen fuel cell buses.</p><p> </p> answering member constituency Chelsea and Fulham answering member printed Greg Hands question first answered 14/06/2022 13:26:36 answering member 1526 label Biography information for Greg Hands
tabling member	4470 label Biography information for Alan Brown

1465692

registered interest
date	25/05/2022
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Transport: Hydrogen
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment his Department has made of the potential role of hydrogen transport in delivering the increased hydrogen production target set out in the British energy security strategy.
tabling member constituency	Kilmarnock and Loudoun
tabling member printed	Alan Brown
uin	9041
answer	answer is ministerial correction date of answer 13/06/2022 answer text <p>Hydrogen will be fundamental to achieving the full decarbonisation of UK transport. The UK has increased its ambition for up to 10GW of low carbon hydrogen production capacity by 2030. Government analysis, set out in the UK Hydrogen Strategy, shows that transport will be a leading early market for low carbon hydrogen, with up to 6TWh demand in 2030 and up to 45TWh demand in 2035. The Government is exploring all options for low carbon hydrogen use across road freight, buses, trains, maritime and aviation to support the development of a thriving UK hydrogen sector – including through the recently announced £200m Zero Emission Road Freight Demonstrator programme and £206m UK Shipping Office for Reducing Emissions (UK SHORE).</p> answering member constituency Chelsea and Fulham answering member printed Greg Hands question first answered 13/06/2022 06:43:15 answering member 1526 label Biography information for Greg Hands
tabling member	4470 label Biography information for Alan Brown

1465693

registered interest
date	25/05/2022
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Motor Vehicles: Hydrogen
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with Cabinet colleagues on taking steps to encourage investment in the manufacturing of hydrogen vehicles.
tabling member constituency	Kilmarnock and Loudoun
tabling member printed	Alan Brown
uin	9042
answer	answer is ministerial correction date of answer 20/06/2022 answer text <p>My rt. hon. Friend the Secretary of State for Business, Energy and Industrial Strategy regularly meets his Cabinet colleagues to discuss measures to support the transformation of the road transport sector to net zero, including investment opportunities in hydrogen vehicles.</p> answering member constituency Chelsea and Fulham answering member printed Greg Hands question first answered 20/06/2022 07:52:44 answering member 1526 label Biography information for Greg Hands
tabling member	4470 label Biography information for Alan Brown

1465696

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his policy is on the continuation of the MedTech funding mandate beyond the next cohort, which is expected to be authorised for use from April 2023 into 2024-25.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	9031
answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.</p><p>The MTFM’s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE’s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 9032 9033 9034 question first answered 21/06/2022 12:03:28 answering member 4362 label Biography information for Edward Argar
tabling member	4398 label Biography information for Chris Green

1465697

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the MedTech strategy will reassess the role of the MedTech funding mandate.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	9032
answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.</p><p>The MTFM’s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE’s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 9031 9033 9034 question first answered 21/06/2022 12:03:28 answering member 4362 label Biography information for Edward Argar
tabling member	4398 label Biography information for Chris Green

1465698

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what themes or groupings of technologies are being considered for the subsequent MedTech Funding mandate cohorts.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	9033
answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.</p><p>The MTFM’s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE’s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 9031 9032 9034 question first answered 21/06/2022 12:03:28 answering member 4362 label Biography information for Edward Argar
tabling member	4398 label Biography information for Chris Green

1465699

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria his Department uses in informing decision-making around the selected themes as part of the MedTech funding mandate.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	9034
answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.</p><p>The MTFM’s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE’s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 9031 9032 9033 question first answered 21/06/2022 12:03:28 answering member 4362 label Biography information for Edward Argar
tabling member	4398 label Biography information for Chris Green

1465704

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Hearing Impairment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what support is available to deaf people to access employment within the NHS.
tabling member constituency	Rugby
tabling member printed	Mark Pawsey
uin	8993
answer	answer is ministerial correction date of answer 22/06/2022 answer text <p>The NHS People Plan commits to creating a diverse workforce and reforming staff recruitment and promotion practices to ensure greater inclusivity.</p><p>The Workforce Disability Equality Standard (WDES) is a mandated framework of ten measures, including recruitment, which compares the workplace experiences of disabled and non-disabled staff. National Health Service organisations use the data collected to develop action plans and it provides comparative information to demonstrate progress. Following the WDES’s data analysis report in 2021, recommendations include developing opportunities for local unemployed disabled people to gain work experience within NHS organisations and convening inclusive recruitment panels to include disabled staff, particularly for senior roles.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 22/06/2022 14:32:28 answering member 4362 label Biography information for Edward Argar
tabling member	4052 label Biography information for Mark Pawsey

1465713

registered interest
date	25/05/2022
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Iran: Espionage and Terrorism
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if she will make an assessment of the possibility of Iran being engaged in espionage and terrorism in the UK through its embassy and diplomats.
tabling member constituency	Chesterfield
tabling member printed	Mr Toby Perkins
uin	8986
answer	answer is ministerial correction date of answer 10/06/2022 answer text <p>It is the longstanding policy of successive British Governments not to comment on intelligence matters.</p><p>The UK has over 200 sanctions designations in place against Iran including in relation to human rights, nuclear proliferation and terrorism. This includes against the Islamic Revolutionary Guard Corps in its entirety. The UK is committed to working with the international community to ensure Iran abides by international laws and norms and is held to account for its destabilising activity in the region.</p> answering member constituency Braintree answering member printed James Cleverly question first answered 10/06/2022 13:39:51 answering member 4366 label Biography information for James Cleverly
tabling member	3952 label Biography information for Mr Toby Perkins